| Literature DB >> 30111298 |
Petter Andreas Ringen1, Ragnhild S Falk2, Bjørnar Antonsen3, Ann Faerden4, Asgeir Mamen5, Eline B Rognli6, Dag K Solberg7, Egil W Martinsen8, Ole A Andreassen9.
Abstract
BACKGROUND: People with severe mental illness have markedly reduced life expectancy; cardiometabolic disease is a major cause. Psychiatric hospital inpatients have elevated levels of cardiometabolic risk factors and are to a high degree dependent of the routines and facilities of the institutions. Studies of lifestyle interventions to reduce cardiometabolic risk in psychiatric inpatients are few. The current study aimed at assessing the feasibility and effects of a lifestyle intervention including Motivational Interviewing (MI) on physical activity levels, cardiometabolic risk status and mental health status in psychotic disorder inpatients.Entities:
Keywords: Cardiometabolic; Cardiovascular; Inpatient; Intervention; Lifestyle; Motivation; Physical activity; Psychosis; Schizophrenia
Mesh:
Year: 2018 PMID: 30111298 PMCID: PMC6094458 DOI: 10.1186/s12888-018-1832-6
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Fig. 1Design: Assessment periods at each ward. Months before (M-X) and after (MX) start of interventions. Dark grey: Intervention period
Linear mixed model analyses of clinical assessments at the Baseline, Start and End time points; estimation of marginal means (EMM) of time with standard errors (S.E)
| Variables | Na | n | BASELINE | n | START | n | END | |||
|---|---|---|---|---|---|---|---|---|---|---|
| EMM | S.E. | EMM | S.E. | EMM | S.E. | |||||
| Physical Activity Index | 58 | 21 | 3.6 | .6 | 51 | 3.0 | .3 | 18 | 3.1 | .5 |
| Daily hours of inactivity | 56 | 23 | 8.6 | .7 | 47 | 8.0 | .5 | 17 | 7.4 | .7 |
| Motivation, importance | 72 | 55 | 7.0 | .4 | 49 | 7.0 | .4 | 19 | 6.4 | .6 |
| Motivation, readiness | 72 | 54 | 5.9 | .4 | 48 | 6.3 | .4 | 19 | 5.5 | .6 |
| Self-esteem (Rosenberg) | 60 | 21 | 25.7 | .6 | 52 | 27.0 | 1.0 | 19 | 28.8 | 1.4 |
| Life satisfaction | 58 | 48 | 3.8 | .2 | 18 | 3.5 | .3 | 26 | 3.7 | .2 |
| GAF S | 50 | 20 | 39.0 | 1.8 | 49 | 37.0 | 1.8 | 25 | 36.7 | 2.2 |
| GAF F | 50 | 20 | 37.8 | 1.6 | 49 | 36.1 | 1.6 | 25 | 38.1 | 2.2 |
| PANSS positive | 60 | 18 |
| 1.3 | 57 | 19.6 | 1.1 | 23 | 18.2 | 1.3 |
| PANSS negative | 60 | 17 | 20.1 | 1.7 | 56 | 21.3 | 1.6 | 23 | 19.9 | 1.2 |
| PANSS general | 60 | 17 | 43.3 | 2.3 | 56 | 39.6 | 1.5 | 23 | 38.2 | 1.8 |
| MADRS | 71 | 16 |
| 1.1 | 57 |
| .9 | 23 | 10.3 | 1.1 |
| AES-C Apathy | 53 | 19 | 39.7 | 2.0 | 42 | 36.7 | 1.2 | 18 | 37.7 | 1.7 |
| BMI, kg/m2 | 59 | 54 | 29.3 | .9 | 34 | 30.0 | 1.0 | 17 | 29.4 | 0.9 |
| Waist, cm | 39 | 24 | 110.5 | 2.6 | 26 | 109.7 | 3.1 | 13 | 109.5 | 3.1 |
| Glucose, mmol/L | 57 | 21 | 5.6 | .1 | 46 | 5.5 | .1 | 17 | 5.5 | .1 |
| HbA1C, % | 58 | 22 | 5.6 | .2 | 48 | 5.4 | .1 | 16 | 5.6 | .1 |
| Insulin, pmol/L | 32 | 0 | – | – | 24 | 99.6 | 11.7 | 12 | 123.6 | 20.2 |
| Cholesterol, mmol/L | 57 | 22 | 5.1 | .2 | 47 | 5.4 | .1 | 17 | 5.2 | .2 |
| Trigycerides, mmol/L | 57 | 22 | 1.8 | .3 | 47 |
| .2 | 17 | 1.5 | .2 |
| HDL-cholesterol, mmol/L | 58 | 22 | 1.1 | .1 | 48 | 1.4 | .2 | 17 | 1.4 | .1 |
| LDL-cholesterol, mmol/L | 57 | 20 | 3.0 | .2 | 47 | 3.4 | .1 | 16 | 3.3 | .2 |
| CRP, mg/L | 25 | 21 | 3.5 | .9 | 11 | 3.8 | 1.2 | 11 | 3.8 | 1.2 |
| Vit DTOT, nmol/L | 21 | 10 |
| 6.5 | 17 | 60.2 | 5.6 | 16 | 58.8 | 4.9 |
a: N of measures included in the linear mixed model. Bold numbers: Comparison with End yields significance at the .05 level. GAF Global Assessment of Functioning, PANSS Positive And Negative Syndrome Scale, MADRS Montgomery Asberg Depression Rating Scale, AES-C Apathy Apathy Evaluation Scale, BMI Body Mass Index, HbA1C Glycosylated Hemoglobin, HDL High Density Lipoprotein Cholesterol, LDL Low Density Lipoprotein, EMM Estimated Marginal Means, S.E Standard Error
Adjusted linear mixed model analysis of physical activity (PA Index) at the Baseline, Start and End time points; estimation of fixed effects
| Variable | Coefficient | 95% CI | p | |
|---|---|---|---|---|
| Time | BL | 0.49 | −0.00 to 0.97 | .050 |
| Start | −0.38 | −1.53 to 0.76 | .498 | |
| End | (ref) | |||
| Motivation, importance | 0.23 | 0.14 to 0.32 | <.001 | |
| Time | BL | 0.37 | −0.23 to 0.96 | .199 |
| Start | −0.45 | −1.78 to 0.89 | .496 | |
| End | (ref) | |||
| Motivation, readiness | 0.17 | 0.04 to 0.30 | .011 | |
| Time | BL | 0.50 | .09 to 0.91 | .022 |
| Start | 0.24 | −1.04 to 1.52 | .701 | |
| End | (ref) | |||
| PANSS positive | −0.06 | −0.11 to − 0.01 | .016 | |
| Time | BL | 0.53 | −0.21 to 1.27 | .136 |
| Start | 0.28 | −1.06 to 1.61 | .664 | |
| End | (ref) | |||
| MADRS | 0.03 | −0.04 to 0.09 | .394 | |
| Time | BL | 0.78 | −0.25 to 1.80 | .111 |
| Start | −0.19 | −1.45 to 1.07 | .755 | |
| End | (ref) | |||
| AES-C Apathy | −0.06 | −0.14 to 0.03 | .170 | |
| Time | BL | 0.55 | −0.13 to 1.23 | .099 |
| Start | −0.18 | −1.32 to 0.96 | .741 | |
| End | (ref) | |||
| Institution (OUH or SPC) | −0.32 | −1.01 to 0.38 | .365 | |
BL Baseline, PANSS Positive And Negative Syndrome Scale, MADRS Montgomery Asberg Depression Rating Scale, AES-C Apathy Apathy Evaluation Scale, CI confidence intervals